tara-002
Cell therapyexperimental
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Nov 30, 2021 (NCT05085977)
Timeline
Indications
Mechanism of action
- Toll-like receptor 4ACTIVATOR
TLR4 activator
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05871970 | Phase 2 | Oct 18, 2023 | Protara Therapeutics |
| NCT05951179 | Phase 1/Phase 2 (Phase 2) | Sep 15, 2023 | Protara Therapeutics |
| NCT05085990 | Phase 1 | Mar 31, 2023 | Protara Therapeutics |
| NCT05085977 | Phase 1 | Nov 30, 2021 | Protara Therapeutics |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Protara Therapeutics | For profit | 4 | 4 | 2 | 2021 |
1 organizations
Page 1 / 1